Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pharmacodynamics and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: a randomized, placebo-controlled study.
J Clin Pharmacol. 2007 Dec;47(12):1489-97. doi: 10.1177/0091270007306563. Epub 2007 Oct 9.
J Clin Pharmacol. 2007.
PMID: 17925591
Clinical Trial.
Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea.
Ogura M, Kim WS, Uchida T, Uike N, Suehiro Y, Ishizawa K, Nagai H, Nagahama F, Sonehara Y, Tobinai K.
Ogura M, et al. Among authors: sonehara y.
Jpn J Clin Oncol. 2021 Feb 8;51(2):218-227. doi: 10.1093/jjco/hyaa177.
Jpn J Clin Oncol. 2021.
PMID: 33051668
Free PMC article.
Clinical Trial.
Item in Clipboard
Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multicenter phase II trial.
Bae H, Tsuchiya J, Okamoto T, Ito I, Sonehara Y, Nagahama F, Kubota K, Tateishi U.
Bae H, et al. Among authors: sonehara y.
Jpn J Radiol. 2018 Nov;36(11):686-690. doi: 10.1007/s11604-018-0780-x. Epub 2018 Sep 24.
Jpn J Radiol. 2018.
PMID: 30251115
Clinical Trial.
Item in Clipboard
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study.
Kim WS, Fukuhara N, Yoon DH, Yamamoto K, Uchida T, Negoro E, Izutsu K, Terui Y, Nakajima H, Ando K, Suehiro Y, Kang HJ, Ko PS, Nagahama F, Sonehara Y, Nagai H, Tien HF, Kwong YL, Tobinai K.
Kim WS, et al. Among authors: sonehara y.
Blood Adv. 2023 Sep 12;7(17):4903-4912. doi: 10.1182/bloodadvances.2022008615.
Blood Adv. 2023.
PMID: 36661315
Free PMC article.
Clinical Trial.
Item in Clipboard
[Pharmacological profile and clinical study results of darinaparsin (DARVIAS® injection 135 mg), an organic arsenic product, for relapsed or refractory peripheral t-cell lymphoma].
Yao K, Sonehara Y, Nagahama F.
Yao K, et al. Among authors: sonehara y.
Nihon Yakurigaku Zasshi. 2023;158(5):408-418. doi: 10.1254/fpj.23047.
Nihon Yakurigaku Zasshi. 2023.
PMID: 37673618
Clinical Trial.
Japanese.
Item in Clipboard
Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma.
Negoro E, Yamauchi T, Fukuhara N, Yamamoto K, Uchida T, Izutsu K, Maruyama D, Terui Y, Nakajima H, Ando K, Suehiro Y, Choi I, Kanemura N, Nakamura N, Yamamoto G, Maeda Y, Shibayama H, Nagahama F, Sonehara Y, Nagai H, Tien HF, Kwong YL, Kim WS, Tobinai K.
Negoro E, et al. Among authors: sonehara y.
J Clin Exp Hematop. 2023;63(2):108-120. doi: 10.3960/jslrt.23005.
J Clin Exp Hematop. 2023.
PMID: 37380467
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite